Asia Pacific Medical Imaging Market Report: Market Size & Forecast 2026

The Asia Pacific medical imaging market covers modalities such as X-ray, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear imaging, together with the software platforms used to acquire, process, and store diagnostic images. It serves hospitals, diagnostic imaging centers, ambulatory clinics, and research institutions across the region. The market is currently valued at approximately $7.52 billion in 2025 and is forecast to grow at a compound annual rate of about 28.32%, reaching substantially higher levels by the early 2030s.

• •Estimated 2025 market value: ~$7.52 billion, with a CAGR near 28.32% through the forecast horizon
• •Covers hardware (X-ray, MRI, CT, ultrasound, PET/SPECT), software, and related services
• •Primary end users include hospitals, diagnostic centers, and specialty clinics

Demand is being lifted by the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders, all of which require frequent imaging for diagnosis and monitoring. Aging populations in countries like Japan, South Korea, and China are expanding the pool of patients needing advanced diagnostics. At the same time, governments across the region are increasing healthcare capital expenditure, and private hospital chains are investing in modern imaging fleets.

• •Aging populations and a rising chronic disease burden are increasing procedure volumes
• •Public and private healthcare investment is funding new imaging installations and replacements
• •Growing middle-class access to private diagnostics is expanding the addressable patient base

By modality, X-ray and ultrasound currently account for the largest installed bases due to their cost-effectiveness and widespread use, while MRI and CT represent the fastest-growing high-value segments. By application, oncology, cardiology, and neurology are the leading clinical areas, supported by AI-assisted detection and workflow tools. Geographically, China and Japan dominate regional revenue, with India, Australia, South Korea, and Southeast Asian economies contributing rapidly rising shares.

• •X-ray and ultrasound lead in unit volume; MRI and CT lead in revenue growth
• •Oncology, cardiology, and neurology are the top application areas
• •China and Japan hold the largest shares, with India and Southeast Asia showing the highest growth rates

What are the recent trends and outlook?

Artificial intelligence is rapidly being integrated into imaging workflows for lesion detection, quantification, and triage, with vendors embedding AI directly into consoles and PACS platforms. Cloud-based archiving, remote reading services, and tele-radiology are expanding access in tier-2 and tier-3 cities as well as rural areas. Looking ahead, the market is expected to continue its double-digit growth trajectory as hybrid imaging, photon-counting CT, and value-based procurement models gain traction across the region.

• •AI-assisted image analysis and cloud/teleradiology platforms are accelerating adoption
• •Hybrid modalities (e.g., PET/CT, PET/MRI) and photon-counting CT are key innovation frontiers
• •Long-term outlook remains strong, with growth supported by reimbursement reform and digital health initiatives